0 My Account

Effectiveness of ERr 731 in the management of symptomatic perimenopause: clinical significance

Prior JC et al., 2007

Menopause (New York, N.Y.), 14(2), 335-6; author reply 336-8

DOI 10.1097/GME.0b013e318032aaa9 PMID 17290163

Abstract

Prior, Jerilynn C. MD, FRCPC1; Klauss, Vanadin Seifert MD2; Kalyan, Shirin PhD1; Pride, Sheila MD, FRSCPC3

Topics

Perimenopause/Menopause > Treatment > Botanical/Non-Hormonal TherapyPerimenopause/Menopause > Symptom Management > Clinical Significance
Prior JC ERr 731 perimenopause symptom management, rhapontic rhubarb extract ERr 731 menopausal symptoms, symptomatic perimenopause botanical treatment clinical significance, ERr 731 phytoestrogen perimenopause effectiveness, Prior Kalyan perimenopause non-hormonal treatment, herbal remedy menopausal vasomotor symptom management, botanical extract perimenopause hot flash treatment, non-hormonal perimenopause therapy clinical effectiveness, rhubarb extract estrogen receptor symptomatic menopause, plant-based perimenopause treatment clinical significance
PMID 17290163 17290163 DOI 10.1097/GME.0b013e318032aaa9 10.1097/GME.0b013e318032aaa9

Cite this article

Prior, J. C., Klauss, V. S., Kalyan, S., & Pride, S. (2007). Effectiveness of ERr 731 in the management of symptomatic perimenopause: clinical significance. *Menopause (New York, N.Y.)*, *14*(2), 335-6; author reply 336-8. https://doi.org/10.1097/GME.0b013e318032aaa9

Related articles

Effect of the use of prediagnosis hormones on breast cancer prognosis: MCC-Spain study
Alonso-Molero J et al., 2022 Menopause (New York, N.Y.)

Objective: To extend knowledge about the long-term use of hormones in hormone therapy or oral contraception as prognostic factors in breast cancer. Methods: The MCC-Spain project is a cohort of 1,685...

Contraception/Comparison > Oral Contraceptives > Cancer RiskContraception/Comparison > Safety > Long-term Health OutcomesPerimenopause/Menopause > Hormone Therapy > Breast Cancer Prognosis

Hot flushes and night sweats differ in associations with cardiovascular markers in healthy early postmenopausal women
Hitchcock CL et al., 2012 Menopause (New York, N.Y.)

Objective: The aim of this study was to evaluate the associations between vasomotor symptoms ([VMS] hot flushes or flashes and night sweats) and markers of cardiovascular risk. Methods: Healthy postm...

Perimenopause/Menopause > Symptoms > Vasomotor SymptomsPerimenopause/Menopause > Comorbidities > Cardiovascular RiskResearch Methodology > Clinical Trials > Randomized Controlled Trial

Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women
Hitchcock CL et al., 2012 Menopause (New York, N.Y.)

Objective: The aim of this study was to compare oral micronized progesterone (progesterone) with placebo as therapy for postmenopausal hot flushes and night sweats (vasomotor symptoms [VMS]). Methods...

Perimenopause/Menopause > Vasomotor Symptoms > Progesterone TherapyPerimenopause/Menopause > Treatment > Bioidentical HormonesResearch Methodology > Randomized Controlled Trials > Placebo-Controlled

Estrogen therapy and risk of breast cancer in postmenopausal women: a case-control study and results of a multivariate analysis
Lumachi F et al., 2010 Menopause (New York, N.Y.)

Objective: Several randomized trials and observational studies show that the use of hormone therapy (HT) increases the risk of breast cancer (BC). The aim of this study was to assess the effects of ex...

Contraception/Comparison > Oral Contraceptives > Breast Cancer RiskPerimenopause/Menopause > Hormone Therapy > Breast Cancer RiskResearch Methodology > Epidemiology > Case-Control Study Design